(Q44753424)

6 December 2017

title

Treatment of epilepsy to optimize bone health (English)

1 reference

6 December 2017

Alison M Pack

1

1 reference

6 December 2017

publication date

1 August 2011

1 reference

Current treatment options in neurology

6 December 2017

published in

1 reference

6 December 2017

volume

13

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

346-354

1 reference

Bone health in people with epilepsy: is it impaired and what are the risk factors?

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Balance impairment in chronic antiepileptic drug users: a twin and sibling study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Bone health in women with epilepsy: clinical features and potential mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Risk of extremity fractures in adult outpatients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Exposure to antiepileptic drugs and the risk of hip fracture: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Fracture risk associated with use of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Antiepileptic drug-induced bone loss in young male patients who have seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Effect of antiepileptic drugs on bone density in ambulatory patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Effect of carbamazepine and valproate on bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Bone consequences of epilepsy and antiepileptic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Bone mineral density in children, adolescents, and young adults with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

The effect of anti epileptic drug therapy on serum 25-hydroxyvitamin D and parameters of calcium and bone metabolism--a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Bone mineral density and its change in pre-and perimenopausal white women: the Michigan Bone Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Antiepileptic drug use increases rates of bone loss in older women: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Evaluation of bone turnover in epileptic children using oxcarbazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

A 12-month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Antiepileptic drug use and rates of hip bone loss in older men: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Bone mineral density with lamotrigine monotherapy for epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Effect of chronic carbonic anhydrase inhibitor therapy on bone mineral density in white women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Amygdaloid kindled seizures can induce functional and pathological changes in thymus of rat: role of the sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

BsmI vitamin D receptor's polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Incidence of Fractures among Epilepsy Patients: A Population-based Retrospective Cohort Study in the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0133-X

Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy

21 January 2018

1 reference

12 December 2020

Bone density and antiepileptic drugs: a case-controlled study

1 reference

12 December 2020

Progressive bone deficit in epilepsy

1 reference

12 December 2020

Increased bone turnover in epileptic patients treated with carbamazepine

1 reference

12 December 2020

Epilepsy, osteoporosis and fracture risk - a meta-analysis

1 reference

12 December 2020

Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone

1 reference

12 December 2020

Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy

1 reference

12 December 2020

Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy

1 reference

12 December 2020

Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism

1 reference

12 December 2020

Genetic variation may clarify the relationship between epilepsy, antiepileptic drugs, and bone health

1 reference

12 December 2020

Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy

1 reference

12 December 2020

A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy

1 reference

12 December 2020

Gender differences in bone mineral density in epilepsy

1 reference

12 December 2020

10.1007/S11940-011-0133-X

Identifiers

DOI

1 reference

6 December 2017

1 reference